Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate Selection for IgA Nephropathy Program

– IgA protease candidate in combination with ImmTOR further enhances pipeline –

– Novel mechanism of action of IgA protease has the potential to address the underlying kidney pathophysiology of IgA nephropathy –

Read more at globenewswire.com